This study explored whether the 2 -adrenergic receptor ( 2 -AR) single nucleotide polymorphism at amino acid 16 (Arg16Gly) has functional effects on skeletal muscle mass, torque production and motor unit behaviour in young, healthy men. Twenty-eight recreationally active men (mean ± SD 23.1 ± 1.3 years of age) were genotyped for Arg16Gly polymorphisms of 2 -AR as arginine homozygous (ArgArg; n = 5), glycine homozygous (GlyGly; n = 11) or arginine-glycine heterozygous (ArgGly; n = 12). The participants then completed body composition testing, assessments of leg extensor size and echo intensity, and evoked and voluntary isometric leg-extension muscle actions. During the evoked muscle actions, peak twitch torque, peak rate of torque development and peak relaxation rate were assessed. During the voluntary muscle actions, maximal voluntary isometric (MVIC) strength was assessed, and surface EMG signals were obtained during submaximal isometric muscle actions and later decomposed to examine motor unit firing behaviour.
INTRODUCTION
-Adrenergic receptors are members of the G-protein-coupled superfamily of receptors and selectively couple to heterotrimetric G-protein (G ; Ryall, Church, & Lynch, 2010) . Found in ∼10-fold greater concentrations than 1 -or 3 -adrenergic receptors, 2 -adrenergic receptors ( 2 -ARs) are the most abundant adrenergic receptors in skeletal muscle. Although an exhaustive description of the 2 -AR signalling pathway is outside the scope of this Introduction (see Berdeaux & Stewart, 2012; Egerman & Glass, 2014; Sato, Shirato, Tachiyashiki, & Imaizumi, c 2018 The Authors. Experimental Physiology c 2018 The Physiological Society Reiken et al., 2003) . Moreover, cAMP and PKA can directly inhibit the calcium-mediated proteases that degrade myofibrils, known as calpains (Navegantes, Resano, Migliorini, & Kettelhut, 2001 ). The G dimer of the 2 -AR initiates the phosphoinositol 3-kinase (PI3K-AKT) signalling pathway independent of G , leading to the phosphorylation of AKT and, subsequently, activation of proteins involved in gene transcription, cell proliferation and survival, and protein synthesis (e.g. the AKT/mTOR and AKT/FOXO pathways; Egerman & Glass, 2014) . Therefore, 2 -AR-mediated signalling is complex and can influence skeletal muscle by regulating both muscle protein synthesis and muscle protein degradation.
Based on the role of the 2 -AR in skeletal muscle, it is unsurprising that a large and growing body of evidence has suggested that -AR agonist treatment enhances muscle mass and function in animal models and in humans (Church et al., 2014; Hinkle et al., 2002; Kalsen, Hostrup, Soderlund, et al., 2016; Kissel et al., 2001; Maltin et al., 1993) . For example, Kamalakkannan et al. (2008) observed a significant increase in lean mass and maximal strength after clenbuterol administration in chronic heart failure patients. Jessen et al. (2018) Remarkeably, despite the widespread investigation of the effects of -AR agonists on skeletal muscle mass and function, to our knowledge, no studies have examined how 2 -AR polymorphisms might influence skeletal muscle size and function. Thus, the purpose of the present study was to explore whether the 2 -AR Arg16Gly SNP has (Snyder et al., 2006; Tang et al., 2003) and the previously observed association between the ArgArg variant and endurance performance (Tsianos et al., 2010; Wolfarth et al., 2007) , we hypothesized that GlyGly allele carriers would display greater lean mass and strength than ArgArg or ArgGly allele carriers. We also hypothesized that we would observe corresponding differences in skeletal muscle contractile properties and motor unit firing behaviour between the genotypes.
METHODS

Ethical approval
Before completing the study, all participants were informed of the experimental procedures and completed a written informed consent document. The study procedures were approved by Oklahoma State University's Institutional Review Board (approval no: ED-17-88; approval date: 8/9/2017) for the protection of human participants in accordance with the standards set by the latest revision of the Declaration of Helsinki, except for registration in a database.
Participants
Twenty-eight young, healthy, recreationally trained men (mean ± SD age 23.1 ± 1.3 years, height 176.4 ± 2.2 cm and weight 86.7 ± 5.0 kg) completed this investigation. The participants were genotyped for Arg16Gly polymorphisms (rs1042713) of 2 -AR as follows: arginine homozygous (ArgArg; n = 5), glycine homozygous (GlyGly; n = 11) or arginine-glycine heterozygous (ArgGly; n = 12). All participants reported being free from current or ongoing neuromuscular disorders or musculoskeletal injuries involving the hips, knees or ankles and were non-smokers. Before completing the study, all participants completed a written health and exercise history questionnaire. 
Experimental design
Genotyping
Saliva samples were collected from each participant for DNA analysis using a Oragene ON-500 salvia collection kit (DNA Genotek, Ottawa, Ontario, Canada). The DNA samples were then shipped to the University of Toronto, where they were stored at −80 • C until analysis. Gentoyping was performed using the iPLEX Gold assay with mass-spectrometry-based detection on the Sequenom MassARRAY platform (Agena Bioscience, San Diego, CA, USA) as previously described (Guest, Corey, Vescovi, & El-Sohemy, 2018) To remove salts from the iPLEX reaction products, the samples were diluted with 16 l of water, and 6 mg of Clean Resin (Sequenom) was added to each reaction. The reactions were rotated for ≥10 min, followed by centrifugation at 3,000 g for 5 min. The reaction products were dispensed onto a 384-element SpectroCHIP (Agena Bioscience) using Agena's RS-1000 MassARRAY Nanodispenser and analysed using the Agena's MassARRAY Analyzer Compact. Using the Typer 4.0 software (Agena), plots of the logarithm of height of the low-versus high-mass allele peaks generated cluster plots (Figure 1) , from which the participants were genotyped as ArgArg, ArgGly or GlyGly for the 2 -AR SNP rs1042713 (e.g. Arg16Gly).
Body composition
Height and weight were measured and body composition was assessed using a SFB7 bioimpedance spectroscopy (BIS) device (ImpediMed, Inc., Carlsbad, CA, USA) in accordance with the manufacturer's instructions during the experimental visit. Specifically, after skin preparation, two single-tab electrodes were placed on the right side of the body 5 cm apart on the dorsal surface of the wrist at the midline of the ulnar styloid process and the dorsal surface of the ankle between the medial and lateral malleoli. Next, the participant's height, weight and sex were programmed into the BIS device, and impedance was measured using 256 frequencies between 4 and 1000 kHz to estimate total body water, extracellular fluid and intracellular fluid based on Cole modelling with Hanai mixture theory (Moon et al., 2009 (Moon et al., , 2010 . The BIS device then provided estimations of relative body fat percentage, fat mass (in kilograms) and fat-free mass (in kilograms).
Fat-free mass index was calculated by expressing fat-free mass relative to height squared (in kilograms per square metre) (Trexler et al., 2017) . All body composition assessments were performed after the participants had undergone a 12 h overnight fast. Participants were also instructed to remain euhydrated via ad libitum water intake up to 1 h before the body composition assessment (Moon et al., 2010) .
The intraclass correlation coefficients and coefficients of variation for fat mass, fat-free mass and relative body fat calculated from 17 participants using these methods in our laboratory (unpublished data) are 0.96 and 6.9%, 0.99 and 1.1%, and 0.97 and 3.9%, respectively.
Ultrasonography
Ultrasound images of the leg extensors were obtained using a portable brightness mode (B-mode) ultrasound-imaging device (GE LOGIQ S8, Wauwatosa, WI, USA) and a multifrequency linear-array probe (model ML6-15-D 4-15 MHz, 50 mm field of view) (Jenkins et al., 2015) .
The participants were positioned on a padded examination table while lying supine with their legs extended, relaxed, supported on the table.
To ensure that the probe moved perpendicular to the skin and along a transverse plane, high-density foam padding was secured to the skin perpendicular to the longitudinal axis of the leg. Great care was taken to ensure that consistent, minimal pressure was applied to the Other (7) F I G U R E 1 An example cluster plot of logarithm height of the low-versus high-mass allele peaks, from which the participants were genotyped as ArgArg (inverted orange triangles), ArgGly (green squares) or GlyGly (blue triangles) for the 2 -adrenergic receptor single nucleotide polymorphism rs1042713
probe to limit compression of the muscle. To enhance acoustic coupling and reduce near field artefacts, a generous amount of water-soluble transmission gel was applied to the skin. All panoramic ultrasound measurements were taken at 50% of the distance from the anterior superior illiac spine to the medial, superior border of the patella (Jenkins et al., 2015; Korhonen et al., 2009 ) and were performed by the same investigator. GE Logiq e LogicView software was used to produce panoramic images of the VL and RF in real time, and analyses of VL and RF muscle cross-sectional area (mCSA) and EI were determined using Image-J Software (version 1.8v; National Institutes of Health, Bethesda, MD, USA) as described in detail previously (Jenkins et al., 2015) . These measurements have been reported to demonstrate high relative (intraclass correlation coefficients = 0.94-0.99) and absolute (coefficients of variation ≤3.5%) reliability in young adults (Jenkins et al., 2015) .
The muscle mCSA of the VL and RF were added together to create a composite mCSA value, which was used in analysis. A weighted EI value for the VL and RF was used for analysis by calculating the relative contribution of the VL and RF to the composite mCSA for each individual, multiplying these coefficients by the participant's EI values for the VL and RF, and adding them together as follows:
Evoked and voluntary isometric muscle strength
For all isometric strength testing, participants were seated on an isokinetic dynamometer (Biodex System 4; Biodex Medical Systems, Inc., were displayed on an external computer monitor. Once the location was determined, the skin was marked, and all further stimuli were delivered at the marked location. Maximal peak-to-peak M-wave amplitude (M P-P ) and twitch torque were achieved by increasing amperage in 2-20 mA increments until a plateau in twitch force and M P-P were observed after three consecutive amperage increases. To ensure a supramaximal stimulus, 120% of the stimulus used to evoke the maximal M-wave and twitch torque was used to evoke the leg extensor muscles with two singlet stimuli while the participant was relaxing.
Following the evoked isometric muscle actions, participants During each ramp muscle action, surface EMG signals were collected from the participant's VL muscle using a specialized five-pin electrode array and a 16-channel Bagnoli data acquisition unit (Delsys Inc., Natick, MA, USA). Before placement of the array, the skin was carefully prepared by shaving, abrading, and cleansing with alcohol.
The five-pin array was then secured to the skin above the VL with hypoallergenic tape in accordance with the recommendations set forth by Zaheer, Roy, and De Luca (2012) . A reference electrode (Dermatrode;
American Imex, Irvine, CA, USA) was placed over the spinous process of the seventh cervical vertebra.
Signal processing
During the voluntary and evoked muscle actions, the torque signal was sampled at 20 kHz, recorded on a personal computer, and analysed offline using custom-written software. Specifically, the torque signals were low-pass filtered with a fourth-order, zero-phase shift Butterworth filter (20 Hz cut-off). During the voluntary muscle actions, MVIC strength was determined as the greatest average torque value achieved during a 500 ms epoch. Previously, we have reported that MVIC strength demonstrates high relative (intraclass correlation coefficient = 0.96) and absolute (coefficient of variation = 5.5%) reliability in young adults (Jenkins et al., 2015) . During the evoked muscle actions, pTT was determined as the greatest torque value, and +dT/dt and −dT/dt were determined as the positive and negative peaks of the first derivative torque signal, respectively (Jenkins et al., 2017) .
During the submaximal ramp muscle actions at 50 and 70% MVIC, the four channels of raw EMG signal recorded were low-and high-pass filtered with a fourth-order Butterworth filter (low-pass ; National Instruments, Austin, TX, USA) was then used to analyse the MUs that met the inclusion criteria described above. The MU properties calculated by the LabVIEW program from each muscle action included the RT, which was defined as the relative force (% MVIC) at which the MU first discharged, and the mean firing rate (MFR), which was calculated of as the average firing rate (in pulses per second) during the plateau in the firing curve of each individual MU Muddle et al., 2018) . (Cohen, 1988) , which were interpreted as small (0.2), moderate (0.5) or large (0.8). The Levene statistic was used to assess whether the assumption of homogeneity of variance was violated. If violated, the Brown-Forsythe F-test was used instead of the ANOVA.
Statistical analyses
In the event of a significant Brown-Forsythe F-statistic, post hoc analyses included Games-Howell tests. The level was set at P ≤ 0.05 for all analyses, and SPSS (v. 24; IBM Inc., Armonk, NY, USA) was used for all analyses.
RESULTS
Resistance training history
There were no differences among the ArgArg, ArgGly and GlyGly groups in the hours of resistance training completed each week (F 2,25 = 0.56; P = 0.58), nor in their estimated total resistance training history (e.g. total hours of training; F 2,25 = 0.07; P = 0.94).
Height, weight and body composition
There were no differences among the ArgArg, ArgGly and GlyGly groups in height (F 2,25 = 1.50; P = 0.242;Table 1), weight (F 2,25 = 2.44; P = 0.108; Table 1 ), body fat percentage (F 2,25 = 1.27; P = 0.299) or fat mass (F 2,25 = 1.01; P = 0.379). Fat-free mass, however, was 
Muscle size and echo intensity
Neither mCSA (F 2,25 = 1.30; P = 0.289) nor EI (F 2,25 = 2.98; P = 0.069) was significantly different among genotypes (Figure 4b,c) . (Table 2) . 
Muscle strength
Motor unit firing rate behaviour
DISCUSSION
The primary results of the present study indicated that fat-free mass, fat-free mass index and muscle strength were greater in the GlyGly than the ArgArg group (Figures 3c,d and 4a) . Moreover, the slope of the MFR versus RT relationship was lower in the GlyGly than the ArgArg group during submaximal contractions at 50% MVIC, but greater in GlyGly and ArgGly than in ArgArg allele carriers during submaximal contractions at 70% MVIC ( Figure 5) . Therefore, overall, our results provide preliminary evidence that 2 -AR genotype has a significant effect on fat-free mass, muscle strength and the relationship between motor unit firing rate and recruitment threshold in recreationally trained men, with those who have the GlyGly variant demonstrating greater lean mass and strength than those with the ArgArg allele.
In the present study, we observed a greater fat-free mass and fatfree mass index in the GlyGly versus the ArgArg group (Figure 3c,d ).
However, we did not observe a genotype-dependent difference in mCSA or EI of the VL and RF muscle (P = 0.289 and 0.069, respectively). Nonetheless, the greater observed fat-free mass index for the GlyGly genotype suggests that the Gly16 variant might augment skeletal muscle protein accretion and is thus associated with greater fat-free mass than the Arg16 variant. Although it is unclear how the Arg16Gly polymorphism might be mediating this effect, previous studies examining the effects of this polymorphism in other tissues might provide some clues. For example, Snyder et al. (2006) reported that Gly16 homozygotes had higher 2 -AR lymphocyte densities than Arg16 homozygotes, and that 2 -AR density was directly related to stroke volume and cardiac output. Large et al. (1997) reported greater adipocyte -agonist sensitivity in those expressing the GlyGly and ArgGly than ArgArg variants. Moreover, Dishy et al. In addition to the effects of 2 -AR-mediated signalling on skeletal muscle hypertrophy and/or atrophy, it has been suggested that 2 -AR agonism might induce slow-to-fast myosin heavy chain transformation of skeletal muscle fibres (Lynch, Hayes, Campbell, & Williams, 1996) . It has also been demonstrated that 2 -ARs are found in greater densities in type I than in type II fibres, but that the anabolic response to 2 -AR stimulation is greatest in type II fibres (Burniston, Clark, Tan, & Goldspink, 2006; Ryall, Sillence, & Lynch, 2006) . We observed not only that muscle strength was significantly greater in the GlyGly than the ArgArg group (Figure 4a ), but also that MU behaviour was dependent on 2 -AR genotype. Previous studies Trevino et al., 2016) have observed relationships between type I and type II fibre area and the slope of the MFR versus RT relationship. These studies appear to demonstrate that individuals with greater type II fibre content demonstrate a MFR versus RT relationship characterized by a more negative slope during low-to moderate-force contractions, but a less negative slope during high-force contractions. Interestingly, in the present study, we observed a more negative slope in the GlyGly than the ArgArg group during muscle actions performed at 50% MVIC, but a less negative slope in the GlyGly and ArgGly groups than in the ArgArg group during muscle actions performed at 70% MVIC ( Figure 5 ). Thus, our results, in combination with these previous studies Trevino et al., 2016) , might suggest skeletal muscle fibre-type differences for the 2 -AR genotypes.
Skeletal muscle mass and function are the result of multiple genetic and environmental factors. In the present study, we performed analyses in recreationally trained young men with similar training backgrounds in an attempt to limit competing influences. Overall, our results provide preliminary evidence that the 2 -AR Arg16Gly genotype significantly influences muscularity, muscle strength and motor unit behaviour in young men with similar training histories.
More specifically, the GlyGly group displayed greater a fat-free mass index and muscle strength than the ArgArg group, whereas those expressing the GlyGly and ArgGly variants demonstrated motor unit firing behaviour that has previously been associated with greater type II fibre content. These data might also have important clinical and exercise-related implications. Future, larger-scale studies are needed to examine further the link between SNP rs1042713 genotype, skeletal muscle 2 -AR density and sensitivity, fibre type and the influence of age or training on skeletal muscle function.
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